A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS

Clinical trial NCT07084012 · RECRUITING

Trial details

NCT number: NCT07084012
Sponsor: Shenzhen Wingor Biotechnology Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Ischemic Stroke AIS

Start date: 2025-08-27
Primary completion: 2027-05-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.